Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is an aggressive hematological disease. The incorporation of tyrosine kinase inhibitors (TKIs) into the standard treatment regimen for Philadelphia (Ph)-positive ALL significantly improved clinical outcomes. TKI-based induction chemotherapy, followed by allogeneic...

Descripción completa

Detalles Bibliográficos
Autor principal: Park, Han-Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386894/
https://www.ncbi.nlm.nih.gov/pubmed/32719174
http://dx.doi.org/10.5045/br.2020.S006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386894/
https://www.ncbi.nlm.nih.gov/pubmed/32719174
http://dx.doi.org/10.5045/br.2020.S006

Ejemplares similares